REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharma-Art Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PHARMA-ART Gyogyszerkereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pharma-Art Bt. is based in Hungary. The head office is in Martfu. It operates in the Pharmacies and Drug Stores sector. It was incorporated on June 24, 1999. It currently has a total number of 6 (2024) employees. In 2023, the company reported a net sales revenue increase of 14.48%. Its’ total assets recorded a negative growth of 2.15%. Pharma-Art Bt.’s net profit margin decreased by 0.35% in 2023.

Headquarters
Munkacsy ut 80. 3.
Martfu; Jasz-Nagykun-Szolnok; Postal Code: 5435

Contact Details: Purchase the Pharma-Art Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma-Art Bt. report to view the information.
Outstanding Shares:
Purchase the Pharma-Art Bt. report to view the information.
Registered Capital:
Purchase the Pharma-Art Bt. report to view the information.
Financial Auditors:
Purchase the Pharma-Art Bt. report to view the information.
Incorporation Date:
June 24, 1999
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharma-Art Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.48%▲
Total operating revenue
14.4%▲
Operating profit (EBIT)
2.56%▲
EBITDA
2.98%▲
Net Profit (Loss) for the Period
5.56%▲
Total assets
-2.15%▼
Total equity
51.26%▲
Operating Profit Margin (ROS)
-0.54%▼
Net Profit Margin
-0.35%▼
Return on Equity (ROE)
-14.67%▼
Quick Ratio
0.1%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo